SERPINE1 has been described as a classic marker of TGF-β pathway activation in glioblastoma, and up-regulation of SERPINE1 has been associated with lower survival rates and poor clinical prognosis (Hau et al. 2011). This evidence concerns the gene TGFB1 and glioblastoma.